{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T16:17:25Z","timestamp":1777738645562,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015515","name":"Kementerian Pendidikan Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A6A1A03033084"],"award-info":[{"award-number":["2019R1A6A1A03033084"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ymthe.2022.01.042","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T23:39:22Z","timestamp":1643845162000},"page":"1926-1940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2"],"prefix":"10.1016","volume":"30","author":[{"given":"Vijayakumar","family":"Jawalagatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perumalraja","family":"Kirthika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2950-4080","authenticated-orcid":false,"given":"Chamith","family":"Hewawaduge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-3729","authenticated-orcid":false,"given":"Myeon-sik","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9246-6873","authenticated-orcid":false,"given":"Ji-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6540-8945","authenticated-orcid":false,"given":"Byungkwan","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6949-5011","authenticated-orcid":false,"given":"John Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2022.01.042_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.01.042_bib2","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.01.042_bib3","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.01.042_bib4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41591-021-01347-0","article-title":"SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies","volume":"27","author":"Andreano","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.042_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41564-021-00932-w","article-title":"SARS-CoV-2 variants of interest and concern naming scheme conducive for global discourse","volume":"6","author":"Konings","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymthe.2022.01.042_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.042_bib7","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMc2100362","article-title":"New SARS-CoV-2 variants-clinical, public health, and vaccine implications","volume":"384","author":"Abdool Karim","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.01.042_bib8","article-title":"Serum neutralizing activity of mRNA-1273 against SARS-CoV-2 variants","author":"Choi","year":"2021","journal-title":"Preprint at bioRxiv"},{"key":"10.1016\/j.ymthe.2022.01.042_bib9","doi-asserted-by":"crossref","first-page":"E590","DOI":"10.1016\/S2214-109X(21)00043-7","article-title":"An interactive website tracking COVID-19 vaccine development","volume":"9","author":"Shrotri","year":"2021","journal-title":"Lancet Glob. Heal."},{"key":"10.1016\/j.ymthe.2022.01.042_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jare.2021.07.007","article-title":"Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection","volume":"36","author":"Jawalagatti","year":"2021","journal-title":"J.\u00a0Adv. Res."},{"key":"10.1016\/j.ymthe.2022.01.042_bib11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.chom.2021.06.007","article-title":"Global COVID-19 vaccine inequity: the scope, the impact, and the challenges","volume":"29","author":"Asundi","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2022.01.042_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/d41586-021-02383-z","article-title":"The fight to manufacture COVID vaccines in lower-income countries","volume":"597","author":"Maxmen","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.01.042_bib13","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/iai.63.9.3279-3286.1995","article-title":"A recombinant Salmonella Typhimurium vaccine induces local immunity by four different routes of immunization","volume":"63","author":"Hopkins","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2022.01.042_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3201\/eid0602.000204","article-title":"Vaccines for mucosal immunity to combat emerging infectious diseases","volume":"6","author":"Van Ginkel","year":"2000","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.042_bib15","doi-asserted-by":"crossref","first-page":"109452","DOI":"10.1016\/j.celrep.2021.109452","article-title":"An intranasal vaccine durably protects against SARS-CoV-2 variants in mice","volume":"36","author":"Hassan","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.ymthe.2022.01.042_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal Chad vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.01.042_bib17","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/v7052321","article-title":"Alphaviruses in gene therapy","volume":"7","author":"Lundstrom","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2022.01.042_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"Scheiblhofer","year":"2017","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ymthe.2022.01.042_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-82862-5","article-title":"Causes of death and comorbidities in hospitalized patients with COVID-19","volume":"11","author":"Elezkurtaj","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.01.042_bib20","doi-asserted-by":"crossref","first-page":"eabf1555","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2022.01.042_bib21","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.042_bib22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.01.042_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev-pharmtox-030320-092348","article-title":"Oral biologic delivery: advances toward oral subunit, DNA, and mRNA vaccines and the potential for mass vaccination during pandemics","volume":"61","author":"Coffey","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ymthe.2022.01.042_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0952-7915(02)00364-3","article-title":"The role of dendritic cells during Salmonella infection","volume":"14","author":"Wick","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.042_bib25","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1098\/rsif.2012.0163","article-title":"Dynamics of Salmonella infection of macrophages at the single cell level","volume":"9","author":"Gog","year":"2012","journal-title":"J.\u00a0R. Soc. Interf."},{"key":"10.1016\/j.ymthe.2022.01.042_bib26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S1286-4579(01)01495-2","article-title":"Animal models of Salmonella infections: enteritis versus typhoid fever","volume":"3","author":"Santos","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ymthe.2022.01.042_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0264-410X(91)90129-T","article-title":"Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella Typhi Ty21a vaccine","volume":"9","author":"Kantele","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.042_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1172\/JCI115876","article-title":"Evaluation in volunteers of a candidate live oral attenuated Salmonella Typhi vector vaccine","volume":"90","author":"Hone","year":"1992","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2022.01.042_bib29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/infdis\/163.2.336","article-title":"The human humoral immune response to Salmonella Typhi Ty2la","volume":"163","author":"Forrest","year":"1991","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.042_bib30","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/cid\/ciaa504","article-title":"Review on the recent advances on typhoid vaccine development and challenges ahead","volume":"71","author":"Syed","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.042_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.chom.2021.03.008","article-title":"SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera","volume":"29","author":"Kuzmina","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2022.01.042_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chom.2021.04.007","article-title":"Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization","volume":"29","author":"Wang","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2022.01.042_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","article-title":"Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization","volume":"29","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2022.01.042_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","article-title":"Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study","volume":"22","author":"Twohig","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.042_bib35","doi-asserted-by":"crossref","first-page":"2100509","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100509","article-title":"Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021","volume":"26","author":"Campbell","year":"2021","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ymthe.2022.01.042_bib36","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(21)01358-1","article-title":"SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness","volume":"397","author":"Sheikh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2022.01.042_bib37","article-title":"Comparison of neutralizing antibody titers elicited by mRNA and adenoviral vector vaccine against SARS-CoV-2 variants","author":"Tada","year":"2021","journal-title":"Preprint at bioRxiv"},{"key":"10.1016\/j.ymthe.2022.01.042_bib38","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.01.042_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/JVI.72.1.191-200.1998","article-title":"DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice","volume":"72","author":"Lin","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.042_bib40","doi-asserted-by":"crossref","first-page":"a007252","DOI":"10.1101\/cshperspect.a007252","article-title":"Vaccine design for CD8\u00a0T lymphocyte responses","volume":"1","author":"Koup","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ymthe.2022.01.042_bib41","doi-asserted-by":"crossref","first-page":"e2330","DOI":"10.1371\/journal.pntd.0002330","article-title":"Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge","volume":"7","author":"Henriques","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2022.01.042_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20247-4","article-title":"Neutralizing antibody titres in SARS-CoV-2 infections","volume":"12","author":"Lau","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.01.042_bib43","first-page":"1","article-title":"A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.01.042_bib44","series-title":"Evidence for Antibody as a Protective Correlate for COVID-19 Vaccines. Vaccine","author":"Earle","year":"2021"},{"key":"10.1016\/j.ymthe.2022.01.042_bib45","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.042_bib46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2007.10.011","article-title":"Entry route of Salmonella Typhimurium directs the type of induced immune response","volume":"27","author":"Martinoli","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2022.01.042_bib47","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4049\/jimmunol.171.7.3684","article-title":"CD11b+ Peyer\u2019s patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells","volume":"171","author":"Sato","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2022.01.042_bib48","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/mi.2017.62","article-title":"The regulation of gut mucosal IgA B-cell responses: recent developments","volume":"10","author":"Lycke","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ymthe.2022.01.042_bib49","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1080\/19490976.2020.1777923","article-title":"Deletion of the lon gene augments expression of Salmonella Pathogenicity Island (SPI)-1 and metal ion uptake genes leading to the accumulation of bactericidal hydroxyl radicals and host pro-inflammatory cytokine-mediated rapid intracellular clearance","volume":"11","author":"Kirthika","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ymthe.2022.01.042_bib50","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4049\/jimmunol.163.2.913","article-title":"Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection","volume":"163","author":"Lycke","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2022.01.042_bib51","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ymthe.2022.01.042_bib52","doi-asserted-by":"crossref","first-page":"110947","DOI":"10.1016\/j.envres.2021.110947","article-title":"Copper-impregnated three-layer mask efficiently inactivates SARS-CoV2","volume":"196","author":"Hewawaduge","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.ymthe.2022.01.042_bib53","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1021\/acsnano.0c05975","article-title":"Quantum dot-conjugated SARS-CoV-2 spike pseudo-virions enable tracking of angiotensin converting enzyme 2 binding and endocytosis","volume":"14","author":"Gorshkov","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2022.01.042_bib54","doi-asserted-by":"crossref","first-page":"e152529","DOI":"10.1172\/jci.insight.152529","article-title":"Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice","volume":"6","author":"Asaka","year":"2021","journal-title":"JCI insight"},{"key":"10.1016\/j.ymthe.2022.01.042_bib55","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/bioinformatics\/btt278","article-title":"CAPITO-a web server-based analysis and plotting tool for circular dichroism data","volume":"29","author":"Wiedemann","year":"2013","journal-title":"Bioinformatics"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:05:11Z","timestamp":1761501911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001622000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1525001622000818"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.042","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}